EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of Hemodialysis on Total and Free Lenvatinib Concentrations in a Patient With Metastatic Renal Cell Carcinoma

Takahiro Ito, Shimpei Yamashita iD, Manabu Suno iD, Ayaka Iwata, Yasuo Kohjimoto, Kazuo Matsubara

IJU Case Reports · 2025-11 · 8 (6) · 601-603

DOI: 10.1002/iju5.70099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IJU Case Reports, online erschienen am 22.09.2025. Verfasst von Takahiro Ito und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences Wakayama Medical University Wakayama Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lenvatinib (LEN) concentrations in patients undergoing hemodialysis (HD) have not been examined. Herein, we report the effect of HD on total and free LEN concentrations in a patient with mRCC. Case Presentation The hemodialyzed patient was a 55‐year‐old Japanese male who was treated with 20 mg LEN daily. The area under the plasma concentration–time curve for LEN from 0 to 24 h (AUC 0–24 ) was calculated on Day 8 (off HD) and Day 9 (on HD) after starting administration of LEN. For total LEN on Days 8 and 9, the AUC 0–24 was 2553 and 2783 ng × h/mL, respectively. The free LEN concentration just after HD on Day 9 was 40% lower than that at the same time on Day 8 (1.8 vs. 3.0 ng/mL).

Conclusion

Although the free LEN concentration is reduced just after HD, LEN will have sufficient pharmacological activity on HD days for patients undergoing HD.

Schlagwörter

Stichwörter der Autor:innen

free drug concentrationhemodialysislenvatinibmetastatic renal cell carcinomatherapeutic drug monitoring

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences Wakayama Medical University Wakayama Japan.
  • Department of Urology Wakayama Medical University Wakayama Japan.
  • Department of Pharmacy Wakayama Medical University Hospital Wakayama Japan.

ORCID-Profile: Shimpei Yamashita, Manabu Suno

Zitieren

APA

Ito, T., Yamashita, S., Suno, M., Iwata, A., Kohjimoto, Y., & Matsubara, K. (2025). Effect of Hemodialysis on Total and Free Lenvatinib Concentrations in a Patient With Metastatic Renal Cell Carcinoma. IJU Case Reports, 8(6), 601-603. https://doi.org/10.1002/iju5.70099

Vancouver

Ito T, Yamashita S, Suno M, Iwata A, Kohjimoto Y, Matsubara K. Effect of Hemodialysis on Total and Free Lenvatinib Concentrations in a Patient With Metastatic Renal Cell Carcinoma. IJU Case Reports. 2025;8(6):601-603. doi:10.1002/iju5.70099

BibTeX
@article{Ito2025,
  author = {Ito, Takahiro and Yamashita, Shimpei and Suno, Manabu and Iwata, Ayaka and Kohjimoto, Yasuo and Matsubara, Kazuo},
  title = {Effect of Hemodialysis on Total and Free Lenvatinib Concentrations in a Patient With Metastatic Renal Cell Carcinoma},
  journal = {IJU Case Reports},
  year = {2025},
  volume = {8},
  number = {6},
  pages = {601--603},
  doi = {10.1002/iju5.70099}
}
Kostenlos starten →